CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 16 enrolled
Drug / intervention
colistimethate sodiumdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02288429
NCT02288429N/ACompleted

Evaluation of Steady-state Pharmacokinetic and Pharmacodynamic Properties of Intravenous Colistimethate Sodium in Cystic Fibrosis and Critically Ill Patients

University of Colorado, Denver·observational·Posted Nov 11, 2014·Updated Jun 24, 2019

In Brief

An observational study evaluating colistimethate sodium for Colistin. Completed, enrolled 16 participants across 1 site.

Detailed Summary

Colistin is a polymixin antibiotic used in the treatment of multidrug-resistant gram-negative infections. Given the limited use of colistin and previous challenges with laboratory assays to determine plasma concentrations, there is a lack of knowledge of the pharmacokinetic profile of colistin. The purpose of the investigators observational prospective pharmacokinetic cohort study is to examine the steady-state pharmacokinetic and pharmacodynamic properties of intravenous colistimethate sodium in cystic fibrosis and critically ill patients.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsColistin
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedNov 11, 2014
Enrollment StartSep 1, 2013
Primary CompletionJun 1, 2019
TodayJul 2, 2026
Enrollment to primary: 5.8 yearsPosted 11.6 years ago

Interventions

colistimethate sodiumdrug